# IMI PROTECT (Work Package 2): Calcium Channel Blockers and Cancer

> **NCT01587742** · — · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 1 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** CCB use

## Key facts

- **NCT ID:** NCT01587742
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2014-02
- **Final completion:** 2014-08
- **Target enrollment:** 1 (ACTUAL)
- **Last updated:** 2014-12-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01587742

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01587742, "IMI PROTECT (Work Package 2): Calcium Channel Blockers and Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01587742. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*